After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...
Money Talks News on MSN23h
Shingles Shocker: the Silent Threat to Your Eyesight After 50The risk of shingles-related blindness increases with age, but a more effective vaccine is now available for those 50 and older.
Earlier this year, GSK said it would invest £200 million (around $260 million) in upgrades to its manufacturing network in ...
Verywell Health on MSN49m
Influenza Treatments: How to Get Better at Home or With MedicationInfluenza (the flu) treatments involve lots of rest at home and possibly over-the-counter flu medications and antivirals.
Mr. Xu Wang, Chief Executive Officer of LakeShore Biopharma, commented, "The approval of this Phase III clinical trial for our YSJA rabies vaccine marks a significant milestone in our efforts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback